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Summary. High physical demand and younger age are currently considered contraindications for total an-
kle replacement. The number of Total Ankle Replacements (TAR) is widespread increasing and indications 
are expanding thanks to a steady improvement in prosthetic designs and better outcome. Commentary of 
the literature: in 1999 a study of 100 uncemented STAR™ (Waldemar-Link, Hamburg, Germany) pros-
theses showed a survival rate of 75% at 6.8 years in patients under 50 years old. Other studies (es, Barg 
et Al.) shows the risk of failure age-related in young patients compared to older group. A report of 780 
TAR from the Swedish Ankle Register showed patients with primary or post-traumatic osteoarthritis under 
60 years of age to have a 1.8 higher chance of revision compared to older patients. Discussion: ankle replace-
ment has been traditionally reserved for patients older 50 years old and with low physical demand. Contra-
riwise this belief, TAR have already been used with a wide range of ages, sometimes even patients younger 
than 30 years old. Most of the “negative” score and results showed before are related to “second-generation” 
prosthetic designs, while recent studies used a “third-generation” prosthetic design. Conclusions: recent evi-
dences showed better clinical results and higher satisfaction in people under the age of 50 compared to ankle 
arthrodesis with comparable rate of complications and survivorship. Younger people will have however a 
higher rate of reoperation but in the meantime, they will prevent progressive degeneration of adjacent joints. 
(www.actabiomedica.it)
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Introduction
The number of Total Ankle Replacements (TAR) 
is widespread increasing 1-3 and indications are expand-
ing thanks to a steady improvement in prosthetic de-
signs and better outcome. 
Historically, relative contraindications for TAR 
were: avascular talar osteonecrosis/loss of bone stock 
4-5, smoking, diabetic neuroarthropathy, poor skin con-
ditions 6-7, osteoporosis, non-compliant patient8, high 
physical demand/obesity7-8 and age over 50 years old 9-10.
The “optimal” patient for TAR is said to be physi-
cally low-demanding, non-obese, older (at least over 
50) with end-stage non traumatic primary ankle ar-
thritis and good bone stock.
End-stage ankle osteoarthritis despite being rela-
tively uncommon if compared to hip and knee osteo-
arthritis is associated with worse mental and physical 
disability11.
A substantial difference from hip and knee osteo-
arthritis is the primary cause; from recent studies over-
all 80% of ankle osteoarthritis is post-traumatic 12-13. 
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This difference is especially important because patients 
are usually younger with higher physical demands and 
therefore in these cases TAR would bear more stress14.
In the past, thanks to the belief that arthrodesis 
has a better outcome in younger patients, TAR was 
reserved to older people with low physical demand 15. 
This was due to reports of low clinical scores and early 
failure rates with so-called first and second generations 
TAR.
Recent studies have shown moreover that, when 
compared with ankle arthrodesis, ankle arthroplasty 
can provide similar pain relief and better functional 
outcome 16.
Therefore, such traditional beliefs have slowly 
been disenchanted in the last years thanks to a con-
stant improvement of the biomechanical model and 
prosthetic designs and, nowadays, an ankle joint re-
placement, as well in other districts, is no more a sur-
gery reserved only for old and inactive people. Various 
authors started to utilize TAR in patients under the 
age of 50 and with high-spicily demand 17-19.
However, there’s still controversy in literature 
about this specific topic and there are very few stud-
ies that directly compared results between younger and 
older patients. The goal of this commentary is to sum-
marize the current evidence about age related factors 
in patients undergoing TAR.
Commentary of the literature
Younger age at surgery might influence longevity 
of the implants in two main ways:
1  The prostheses will need to function longer (higher 
life expectancy of the patient).
2  The patient will be more active, and this has been 
proved to be associated with a larger amount 
of polyethylene wear in hip prostheses 20.
A special consideration should be given to pa-
tients with inflammatory joint disease (IJD) because 
of the fact that even if they are younger, they are less 
active due to multiple joints affected 21.
Only few authors directly studied the effect of age 
on results of TAR. In 1999 a study of 100 uncement-
ed STAR™ (Waldemar-Link, Hamburg, Germany) 
prostheses showed a survival rate of 75% at 6.8 years in 
patients under 50. The group over 50 showed a survival 
rate of 81% at 6 years of follow up 22.
Barg et al. 23 found that age under 70 is an inde-
pendent predictor of failure of the Hintegra™ ankle 
prosthesis (Integra™ Neurosciences Implants, Sophia 
Antipolis, France) (average follow up of 6.3 years). 
Another study showed that patient’s underage of 54 
had a 2.65 times greater risk of failure compared to 
older patients. Their estimated rate of survival at 61 
months was 0.74 for the younger group vs 0.89 of the 
older group 24.
A report of 780 TAR from the Swedish Ankle 
Register showed patients with primary or post-trau-
matic osteoarthritis under 60 years of age to have a 1.8 
higher chance of revision compared to older patients 27.
Nevertheless, on the other hand, a review of 103 
Salto third generation prostheses 25 (Salto Talaris™, 
Integra Lifescience Corporation, Austin TX, USA) 
specifically compared patients under 50 age and over 
50 age. In this study both age groups had an equiva-
lent AOFAS score (26.7 points vs 27.0 points) and a 
significative post-operative increase in AOFAS score 
was seen (p<0.001). However, this increase was signifi-
cantly higher in the younger group (mean 66.8 points 
vs 62.8 points). There was no significative difference 
with the preoperative Range Of Motion (ROM) val-
ues in both groups and both groups had their ROM 
significantly improved at follow-up (p<0.001) but the 
younger group had a significantly higher ROM (37.2° 
vs 33.9°; p = 0.020). There was no difference between 
major complications and survival.
Wand et al. reported outcomes of a cohort of 395 
primary Inbone (Inbone™, Wright Medical Group 
NV, Memphis TE,USA), Salto Talaris and Star pros-
theses divided into 3 groups: under 55, between 55-70 
and over 70 26 with an average follow up of 3.5 years. 
There were no differences about wound complications, 
reoperation and revisions.
Discussion 
There’s conflicting evidence of the influence of 
age on TAR survival and, over time, more and more 
studies have been published. Ankle replacement has 
been traditionally reserved for patients older 50 years 
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old and with low physical demand under the assump-
tion that the prostheses would have to bear less stress 
preventing early failure.
Contrariwise this belief, TAR have already been 
used with a wide range of ages, sometimes even in pa-
tients younger than 30 years old 27-28-29. The total ankle 
arthroplasty in young patients requires technical pe-
culiarities such as: removal of the osteophytes, assess-
ment of the joint instability, removal of the medial and 
lateral impingement, subtalar stiffness, gastrocnemius 
contracture and axial deviation (Figure 1).
Most of the “negative” score and results showed 
before are related to “second-generation” prosthetic 
designs, while recent studies used a “third-generation” 
prosthetic design30,31. Despite this, there’s still no con-
sensus as to which is the appropriate age to perform 
TAR and most of the studies conclude that the treat-
ment should be patient-specific 32.
A recent review comparing ankle arthrodesis and 
ankle replacements over the last decade showed an 
overall higher complication rate of ankle arthrodesis 
but a higher reoperation rate for TAR 33. This is espe-
cially true in younger patients who are physically more 
active and with higher life expectancy. Besides ankle 
arthrodesis is associated with poorer results and lower 
patient satisfaction score 34-35.
Altogether, younger patients will live longer with 
a high physical demand and, even if they’ll need a sec-
ond reoperation, TAR will allow them to gain time and 
live a better quality of life while sparing adjacent joints 
from progressive degeneration.
Recent reports showed that younger patients dis-
played better clinical and functional score while the 
rate of complications (minor, such as skin necrosis/ 
intraoperative malleolar fracture or major as reop-
erations) did not statistically differ compared to older 
 patients 25-29,32.
There are however some limitations and the re-
sults don’t have a unique interpretation.
First, in most of the studies patients are evalu-
ated by different surgeons. Second, the number of the 
younger patients are significantly lower if compared to 
older patients.
Even the average follow-up, especially if we 
consider “third generation” prostheses, is short, usu-
ally within 2 years. Another inconsistency is the used 
scores, that differ among the studies. The most widely 
used is the AOFAS score which, unless it allows direct 
comparison, has already been criticised for what con-
cerns the validity of its clinical-base score 35-36.
Last, almost no one of the studies went in-depth 
about the exact cause of the reported implant failures.
Figure 1. Clinical cases of a 43 years old male affected by post-traumatic osteoarthritis of the left ankle following a pilon fracture 4 
years before; a-b: Antero-posterior and lateral view X-ray of the ankle pre-operatively; c-d:  X-ray at 3 years follow-up after removal 
of the impingement and the implant of a total ankle replacement (Box prosthesis).
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Conclusions
The reported results might support the hypothesis 
that ankle replacements are a valid and effective treat-
ment for young and physically active patients. Recent 
evidences showed better clinical results and higher sat-
isfaction in people under the age of 50 compared to 
ankle arthrodesis with comparable rate of complica-
tions and survivorship. 
Younger people will have however a higher rate 
of reoperation but in the meantime, they will prevent 
progressive degeneration of adjacent joints.
Choosing between TAR and ankle arthrodesis 
should be however patient-specific because other fac-
tors (as patient expectation and activity level or other 
comorbidities such as diabetes, neuroarthropathy or 
inflammatory joint disease) might have an important 
role.
Lastly, further studies and longer follow-ups are 
needed.
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